<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04822870</url>
  </required_header>
  <id_info>
    <org_study_id>2021-Z-01</org_study_id>
    <nct_id>NCT04822870</nct_id>
  </id_info>
  <brief_title>Comparison of Ultrasound-guided Quadratus Lumborum Block and Iliohypogastric/Ilioinguinal Nerve Block for Postoperative Pain Management in Patients Undergoing Cesarean Section</brief_title>
  <official_title>Comparison of Ultrasound-guided Quadratus Lumborum Block and Iliohypogastric/Ilioinguinal Nerve Block for Postoperative Pain Management in Patients Undergoing Cesarean Section: a Randomized Double-blind Clinical Trial Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking University People's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking University People's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the analgesic effect of ultrasound-guided quadratus&#xD;
      lumborum block and iliohypogastric/ilioinguinal nerve block for postoperative pain management&#xD;
      in patients undergoing cesarean section.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">March 31, 2021</start_date>
  <completion_date type="Anticipated">May 2021</completion_date>
  <primary_completion_date type="Anticipated">May 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>morphine consumption</measure>
    <time_frame>24 hours postoperatively</time_frame>
    <description>Every parturient use a patient-controlled intravenous analgesia pump as supplement for the interventions. The analgesia pump contains morphine and can record morphine consumption. Postoperative use of morphine can reflect analgesic effect.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>morphine consumption</measure>
    <time_frame>6 hours postoperatively</time_frame>
    <description>Every parturient use a patient-controlled intravenous analgesia pump as supplement for the interventions. The analgesia pump contains morphine and can record morphine consumption. Postoperative use of morphine can reflect analgesic effect.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>morphine consumption</measure>
    <time_frame>12 hours postoperatively</time_frame>
    <description>Every parturient use a patient-controlled intravenous analgesia pump as supplement for the interventions. The analgesia pump contains morphine and can record morphine consumption. Postoperative use of morphine can reflect analgesic effect.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>morphine consumption</measure>
    <time_frame>48 hours postoperatively</time_frame>
    <description>Every parturient use a patient-controlled intravenous analgesia pump as supplement for the interventions. The analgesia pump contains morphine and can record morphine consumption. Postoperative use of morphine can reflect analgesic effect.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pain score</measure>
    <time_frame>6 hours postoperatively</time_frame>
    <description>Use visual analogue scale (VAS) 0-10 to evaluate pain intensity and reflect analgesic effect. 0 refers to completely no pain, 10 refers to the most severe pain she has experienced.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pain score</measure>
    <time_frame>12 hours postoperatively</time_frame>
    <description>Use visual analogue scale (VAS) 0-10 to evaluate pain intensity and reflect analgesic effect. 0 refers to completely no pain, 10 refers to the most severe pain she has experienced.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pain score</measure>
    <time_frame>24 hours postoperatively</time_frame>
    <description>Use visual analogue scale (VAS) 0-10 to evaluate pain intensity and reflect analgesic effect. 0 refers to completely no pain, 10 refers to the most severe pain she has experienced.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pain score</measure>
    <time_frame>48 hours postoperatively</time_frame>
    <description>Use visual analogue scale (VAS) 0-10 to evaluate pain intensity and reflect analgesic effect. 0 refers to completely no pain, 10 refers to the most severe pain she has experienced.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>effective analgesia time</measure>
    <time_frame>48 hours postoperatively</time_frame>
    <description>Time period between finish the intervention and the first time parturient use the patient-controlled intravenous analgesia pump for analgesia supplement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>adverse effect</measure>
    <time_frame>6 hours postoperatively</time_frame>
    <description>Nausea and vomiting, pruritus, oversedation, respiratory depression and urinary retention are considered adverse effects. The incidence and severity are recorded, 1 score refers to mild, 2 scores refers to moderate, 3 scores refers to severe and treatment needed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>adverse effect</measure>
    <time_frame>12 hours postoperatively</time_frame>
    <description>Nausea and vomiting, pruritus, oversedation, respiratory depression and urinary retention are considered adverse effects. The incidence and severity are recorded, 1 score refers to mild, 2 scores refers to moderate, 3 scores refers to severe and treatment needed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>adverse effect</measure>
    <time_frame>24 hours postoperatively</time_frame>
    <description>Nausea and vomiting, pruritus, oversedation, respiratory depression and urinary retention are considered adverse effects. The incidence and severity are recorded, 1 score refers to mild, 2 scores refers to moderate, 3 scores refers to severe and treatment needed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>adverse effect</measure>
    <time_frame>48 hours postoperatively</time_frame>
    <description>Nausea and vomiting, pruritus, oversedation, respiratory depression and urinary retention are considered adverse effects. The incidence and severity are recorded, 1 score refers to mild, 2 scores refers to moderate, 3 scores refers to severe and treatment needed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>satisfaction score</measure>
    <time_frame>48 hours postoperatively</time_frame>
    <description>Ask the patient to evaluate satisfaction score using 0-10. 0 refers totally dissatisfied, 10 refers to the most satisfied</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hospital stay</measure>
    <time_frame>at discharge assessed up to 10 days</time_frame>
    <description>The hospitalize length</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hospitalize cost</measure>
    <time_frame>at discharge assessed up to 10 days</time_frame>
    <description>Total cost in this hospitalization</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">87</enrollment>
  <condition>Quadratus Lumborum Block</condition>
  <condition>Iliohypogastric/Ilioinguinal Nerve Block</condition>
  <condition>Cesarean Section</condition>
  <arm_group>
    <arm_group_label>quadratus lumborum block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Parturients receive ultrasound-guided quadratus lumborum block as post-operative analgesia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>iliohypogastric/ilioinguinal nerve block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Parturients receive ultrasound-guided iliohypogastric/ilioinguinal nerve block as post-operative analgesia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>epidural analgesia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Parturients receive epidural morphine via epidural catheter placed during anesthesia as post-operative analgesia.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>quadratus lumborum block</intervention_name>
    <description>Quadratus lumborum block is an effective nerve block method in post-cesarean section analgesia. It is a relatively new technique that may provide analgesic effect in somatic pain and visceral pain, but has not been verified yet.</description>
    <arm_group_label>quadratus lumborum block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>iliohypogastric/ilioinguinal nerve block</intervention_name>
    <description>Iliohypogastric/ilioinguinal nerve block is a widely used nerve block technique. It can provide somatic analgesia effect in post-cesarean section.</description>
    <arm_group_label>iliohypogastric/ilioinguinal nerve block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>epidural analgesia</intervention_name>
    <description>Epidural analgesia is a traditional analgesia method. Epidural morphine can provide effective analgesia but may cause plenty adverse effect.</description>
    <arm_group_label>epidural analgesia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  singleton pregnancy&#xD;
&#xD;
          -  gestation of at least 37 weeks&#xD;
&#xD;
          -  American Society of Anesthesiologists (ASA) physical status I or II&#xD;
&#xD;
          -  finish Pfannenstiel section under combined spinal and epidural anesthesia&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  pruritus existed before the surgery&#xD;
&#xD;
          -  allergic to lidocaine, ropivacaine or dexamethasone&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yi Feng, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Peking University People's Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Peking University People's Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100044</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>March 17, 2021</study_first_submitted>
  <study_first_submitted_qc>March 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 30, 2021</study_first_posted>
  <last_update_submitted>April 2, 2021</last_update_submitted>
  <last_update_submitted_qc>April 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Peking University People's Hospital</investigator_affiliation>
    <investigator_full_name>Yi Feng, MD</investigator_full_name>
    <investigator_title>Head of Anesthesiology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

